Latest Novartis Stories
Farmers, exporters, and other Corn industry professionals are suing Biotech Giant Syngenta AG in multi-million dollar claims over China’s rejection of MIR 162 corn. Minneapolis,
- Vanda and Novartis Agree to Settle Arbitration WASHINGTON, Dec. 22, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc.
BASEL, Switzerland, December 22, 2014 /PRNewswire/ -- - Import approval granted for food and feed use - Agrisure Viptera(R) offers unrivalled control
Firms Contend Syngenta Should be Held Accountable for Farmers' Economic Damages DALLAS, Dec.
-- Acromegaly is an endocrine disorder caused by elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels(1) -- Signifor LAR, a next-generation somatostatin
All Federally-Filed Syngenta GMO Corn Lawsuits Accusing the Company of Negligence and Recklessness in Its Handling of GMO Corn Seed Varieties Will Now be Consolidated in U.S.
LONDON, December 12, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Melanoma Drugs - new study showing you trends,
CHICAGO, Dec. 10, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
Syngenta GMO Corn Seed Lawsuits Allege That U.S.